E166-2 – Why Moroccan Hash Struggles in Europe’s Pharmaceutical Cannabis Market with Jan van Weenen - Part 2
FEB 10, 202619 MIN
E166-2 – Why Moroccan Hash Struggles in Europe’s Pharmaceutical Cannabis Market with Jan van Weenen - Part 2
FEB 10, 202619 MIN
Description
Can Morocco’s famous hash industry survive pharmaceutical regulation?In Part 2 of Episode 166, Trevor and Kirk continue their conversation with Jan van Weenen, a European cannabis veteran helping transform Morocco’s ancient hash market into a GMP-compliant pharmaceutical industry. From heavy metals in Rif Mountain soil to pricing battles between farmers, co-ops, and manufacturers, this episode reveals the real-world challenges of global cannabis regulation.Jan shares his strategy to build a pharmaceutical cannabis brand now — and pivot into recreational markets later — while navigating European standards, extract distribution, and international licensing.Listen now to explore the birth of Morocco’s legal cannabis industry and what it means for Europe and beyond.Jan van Ween - LinkedInTranscripts, papers and so much more at: reefermed.ca